Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality. Prognostic biomarkers to identify rapid progressors are urgently needed to improve patient management. Since the lysophosphatidic acid (LPA) pathway has been implicated in lung fibrosis in preclinical models and...

Descripción completa

Detalles Bibliográficos
Autores principales: Neighbors, Margaret, Li, Qingling, Zhu, Sha (Joe), Liu, Jia, Wong, Weng Ruh, Jia, Guiquan, Sandoval, Wendy, Tew, Gaik W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Patient-oriented and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205439/
https://www.ncbi.nlm.nih.gov/pubmed/37075981
http://dx.doi.org/10.1016/j.jlr.2023.100375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205439/
https://www.ncbi.nlm.nih.gov/pubmed/37075981
http://dx.doi.org/10.1016/j.jlr.2023.100375

Ejemplares similares